Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARC001: AR101 in Peanut Allergy
NCT01987817Phase 2Completed
- Start
- Feb 2014
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes, Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of peanut protein in peanut allergy. Started Feb 2014; status: completed.
02
Drugs
peanut protein
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT01987817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987817.